KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Depreciation and Depletion (2016 - 2021)

Historic Depreciation and Depletion for Arbutus Biopharma (ABUS) over the last 9 years, with Q4 2021 value amounting to $474000.0.

  • Arbutus Biopharma's Depreciation and Depletion fell 687.62% to $474000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1.8 million, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of $1.4 million for FY2024, which is 28.49% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Depreciation and Depletion of $474000.0 as of Q4 2021, which was down 687.62% from $447000.0 recorded in Q3 2021.
  • In the past 5 years, Arbutus Biopharma's Depreciation and Depletion registered a high of $620000.0 during Q4 2017, and its lowest value of $334000.0 during Q1 2017.
  • In the last 5 years, Arbutus Biopharma's Depreciation and Depletion had a median value of $502500.0 in 2018 and averaged $501800.0.
  • As far as peak fluctuations go, Arbutus Biopharma's Depreciation and Depletion surged by 10378.01% in 2017, and later tumbled by 1870.97% in 2018.
  • Arbutus Biopharma's Depreciation and Depletion (Quarter) stood at $620000.0 in 2017, then decreased by 18.71% to $504000.0 in 2018, then rose by 0.6% to $507000.0 in 2019, then rose by 0.39% to $509000.0 in 2020, then dropped by 6.88% to $474000.0 in 2021.
  • Its Depreciation and Depletion was $474000.0 in Q4 2021, compared to $447000.0 in Q3 2021 and $436000.0 in Q2 2021.